Related Experiment Video

Updated: Aug 13, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

The Brn-2 transcription factor links activated BRAF to melanoma proliferation

Jane Goodall1, Claudia Wellbrock, Timothy J Dexter

  • 1Signaling and Development Laboratory, Marie Curie Research Institute, The Chart, Oxted, Surrey RH8 0TL, United Kingdom.

Molecular and Cellular Biology
|March 17, 2004
PubMed

Insights

Malignant melanoma often has BRAF mutations. This study reveals that the Brn-2 transcription factor, upregulated by BRAF signaling, drives melanoma cell proliferation, suggesting a new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant melanoma is an aggressive cancer with frequent BRAF mutations (70%).
  • The downstream effects of BRAF signaling on gene expression in melanoma are not well understood.
  • The role of the Brn-2 transcription factor in melanoma pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the role of the Brn-2 transcription factor in BRAF-driven melanoma.
  • To determine the relationship between BRAF signaling and Brn-2 expression.
  • To assess the impact of Brn-2 on melanoma cell proliferation.

Main Methods:

  • Analysis of Brn-2 expression in melanoma cell lines versus normal melanocytes/melanoblasts.
  • Overexpression of Brn-2 in melanocytes to assess proliferation.
  • Investigation of Ras and MAP kinase signaling on Brn-2 expression.
  • Reporter assays to study BRAF mutant stimulation of the Brn-2 promoter.
  • RNA interference to downregulate BRAF and Brn-2.

Main Results:

  • Brn-2 is highly expressed in melanoma cell lines but not in melanocytes or melanoblasts.
  • Overexpression of Brn-2 in melanocytes increases proliferation.
  • Ras and MAP kinase signaling strongly upregulate Brn-2 expression.
  • Kinase-activating BRAF mutants stimulate the Brn-2 promoter.
  • BRAF downregulation inhibits endogenous Brn-2 expression.
  • Depletion of Brn-2 decreases proliferation in melanoma cells with activated BRAF.

Conclusions:

  • High Brn-2 expression in melanomas is linked to BRAF signaling.
  • Brn-2 acts as a downstream mediator of BRAF signaling in melanoma.
  • Brn-2 plays a critical role in promoting melanoma cell proliferation.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...